Mr Loganathan S, AVP, Onesource Biopharma

Speaker in this video:
Mr Loganathan S, AVP, Onesource Biopharma

Topic: The strategic shift: Why CDMOs are becoming central to pharma growth

Key Highlights:
[1] Drug delivery combinations are the fastest-growing CDMO segment, with US DDC sales rising 16% annually, driven mainly by GLP-1s and biologics.

[2] OneSource offers end-to-end capability, from cell line development through to drug device assembly and commercial manufacturing.

[3] OneSource combines strong technical acumen with worldwide quality and regulatory expertise across its manufacturing operations.